DOK2 Antikörper (C-Term)
Kurzübersicht für DOK2 Antikörper (C-Term) (ABIN359960)
Target
Alle DOK2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- C-Term
- 
                                            Spezifität
- This antibody reacts to DOK2.
- 
                                            Aufreinigung
- Protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
- 
                                            Immunogen
- This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the C-terminal region of human DOK2.
- 
                                            Isotyp
- Ig Fraction
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- 
                        ELISA: 1/1,000. Western blotting: 1/100 - 1/500. Immunohistochemistry: 1/50 - 1/100. 
 Other applications not tested.
 Optimal dilutions are dependent on conditions and should be determined by the user.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Konzentration
- 0.25 mg/mL
- 
                                            Buffer
- PBS with 0.09 % (W/V) sodium azide
- 
                                            Konservierungsmittel
- Sodium azide
- 
                                            Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Handhabung
- Avoid repeated freezing and thawing.
- 
                                            Lagerung
- 4 °C/-20 °C
- 
                                            Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
 
- 
                                            
- 
    - DOK2
- 
                                            Andere Bezeichnung
- DOK2 / p56 Dok2
- 
                                            Hintergrund
- Docking proteins interact with receptor tyrosine kinases and mediate particular biological responses using signal transduction. Dok-2 acts as a multiple docking protein downstream of receptor or non-receptor tyrosine kinases. By this mechanism it acts to negatively regulate signal transduction and cell proliferation controlled by cytokines in a feedback loop. Dok-2 is highly expressed in cells and tissues of hematopoietic origin as well as in lung. Expression of bcr/abl induces additional tyrosine phosphorylation of the Dok1 and Dok2 proteins and their association with Ras-GAP. Thus, it is suspected that DOK association regulates GAP activity toward Ras and that the Dok proteins serve as mediators of bcr-abl signaling. The role of Dok proteins in bcr-abl regulation may also be implicated in chronic myelogenous leukemia (CML), which is characterized by a Philadelphia chromosome translocation t(9,22). Such a mutation would result in a p210-bcr/abl chimeric protein-tyrosine kinase which has been found in many CML cases.Synonyms: Docking protein 2, Downstream of tyrosine kinase 2, p56(dok-2), p56Dok-2
- 
                                            Gen-ID
- 9046, 9606
- 
                                            UniProt
- O60496
 Target
- 
                    
 
                                     
                                     
                                    